Yifan Pharmaceutical Co., Ltd. (SHE:002019)

China flag China · Delayed Price · Currency is CNY
15.28
-0.22 (-1.42%)
Aug 14, 2025, 2:45 PM CST
-1.42%
Market Cap18.61B
Revenue (ttm)5.16B
Net Income (ttm)393.03M
Shares Out1.22B
EPS (ttm)0.33
PE Ratio46.95
Forward PE24.68
Dividend0.20 (1.29%)
Ex-Dividend DateMay 29, 2025
Volume20,633,138
Average Volume28,820,151
Open14.87
Previous Close15.50
Day's Range14.87 - 15.65
52-Week Range9.94 - 15.65
Beta0.83
RSI63.32
Earnings DateAug 15, 2025

About Yifan Pharmaceutical

Yifan Pharmaceutical Co., Ltd. engages in the researches and develops, produces, and sells macromolecules, biosimilars, generic drugs, small molecules, synthetic biologics, and special traditional Chinese medicines in China Southeast Asia, Europe, North America, Singapore, South Korea, Italy, Germany, and the United States, and internationally. It offers oral slow controlled release preparations, micron suspensions, micelles for injection, and liquid preparations. The company also focuses on hematologic maliganancies, inflammatory, endocrinolog... [Read more]

Sector Healthcare
Founded 2000
Employees 4,098
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002019
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.